Gamma‐Glutamyltransferase as a Potential Surrogate Marker for Detection of the Non‐A, Non‐B Carrier State
- 1 April 1988
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 54 (3) , 144-147
- https://doi.org/10.1111/j.1423-0410.1988.tb03889.x
Abstract
Alanine aminotransferase (ALT) is currently widely used as a surrogate marker for detection of blood having a higher risk of transmission of non‐A, non‐B hepatitis (NANBH). Studies in the chimpanzee model, in which the NANBH carrier state is well defined, have revealed gamma‐glutamyltransferase to be considerably more sensitive for the detection of NANBH carrier blood. Further study is required to determine whether this marker is also more sensitive for detection of the chronc NANBH carrier state in man.This publication has 10 references indexed in Scilit:
- Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitisHepatology, 1986
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986
- The Clinical Chemistry of Chimpanzees: II. Gamma Glutamyl Transferase Levels in Hepatitis StudiesJournal of Medical Primatology, 1985
- Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion RecipientsAnnals of Internal Medicine, 1984
- Donor Transaminase and Recipient HepatitisJAMA, 1981
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981
- Serum -glutamyl transpeptidase activity in liver diseaseGut, 1972
- The Use of Serum Enzyme Determinations to Detect Anicteric HepatitisTransfusion, 1965
- Serum γ-Glutamyl Transpeptidase Activity in Liver DiseaseGastroenterology, 1961